يعرض 3,801 - 3,820 نتائج من 18,134 نتيجة بحث عن 'significantly ((((larger decrease) OR (((a decrease) OR (nn decrease))))) OR (linear decrease))', وقت الاستعلام: 0.57s تنقيح النتائج
  1. 3801

    Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout حسب Alper James Alcaraz (20977320)

    منشور في 2025
    "…Benchmark concentration analysis of transcriptomic responses at 4 dph, based on the most sensitive transcriptomic features, yielded tPODs between 0.028 and 0.47 μg/L B[<i>a</i>]P. At 28 dph, Cyp1a1 exhibited significantly increased catalytic activity, with biochemical POD, bPOD<sub>EROD,28dph</sub> of 0.599 μg/L B[<i>a</i>]P, while morphometric analysis showed significant growth inhibition in terms of length, with apical POD, aPOD<sub>length,28dph</sub> of 1.77 μg/L B[<i>a</i>]P, with a notable decreasing trend in body weight. …"
  2. 3802

    Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout حسب Alper James Alcaraz (20977320)

    منشور في 2025
    "…Benchmark concentration analysis of transcriptomic responses at 4 dph, based on the most sensitive transcriptomic features, yielded tPODs between 0.028 and 0.47 μg/L B[<i>a</i>]P. At 28 dph, Cyp1a1 exhibited significantly increased catalytic activity, with biochemical POD, bPOD<sub>EROD,28dph</sub> of 0.599 μg/L B[<i>a</i>]P, while morphometric analysis showed significant growth inhibition in terms of length, with apical POD, aPOD<sub>length,28dph</sub> of 1.77 μg/L B[<i>a</i>]P, with a notable decreasing trend in body weight. …"
  3. 3803

    Transcriptomics Points-of-Departure (tPODs) to Support Hazard Assessment of Benzo[<i>a</i>]pyrene in Early-Life-Stage Rainbow Trout حسب Alper James Alcaraz (20977320)

    منشور في 2025
    "…Benchmark concentration analysis of transcriptomic responses at 4 dph, based on the most sensitive transcriptomic features, yielded tPODs between 0.028 and 0.47 μg/L B[<i>a</i>]P. At 28 dph, Cyp1a1 exhibited significantly increased catalytic activity, with biochemical POD, bPOD<sub>EROD,28dph</sub> of 0.599 μg/L B[<i>a</i>]P, while morphometric analysis showed significant growth inhibition in terms of length, with apical POD, aPOD<sub>length,28dph</sub> of 1.77 μg/L B[<i>a</i>]P, with a notable decreasing trend in body weight. …"
  4. 3804
  5. 3805
  6. 3806
  7. 3807
  8. 3808
  9. 3809
  10. 3810

    BT9 reduces DAOY and D425 medulloblastoma cell invasion. حسب Zahra Motahari (6814013)

    منشور في 2024
    "…(C) Compared to control, BT9 treatment significantly decreased the number of invading DAOY and D425 cells (****p < 0.0001, BT9 vs vehicle control, n = 6). 4x magnification.…"
  11. 3811
  12. 3812
  13. 3813
  14. 3814
  15. 3815
  16. 3816

    Oligonucleotides used in this study. حسب Aga E. Gelgie (17661720)

    منشور في 2024
    "…In comparison to the parent strain, the 0690::Tn mutant displayed markedly reduced fitness, as evidenced by a significant decrease or even absence in post-challenge mycoplasma counts in murine and cow mammary tissues, respectively. …"
  17. 3817

    Data supporting the findings of this study. حسب Aga E. Gelgie (17661720)

    منشور في 2024
    "…In comparison to the parent strain, the 0690::Tn mutant displayed markedly reduced fitness, as evidenced by a significant decrease or even absence in post-challenge mycoplasma counts in murine and cow mammary tissues, respectively. …"
  18. 3818
  19. 3819
  20. 3820

    Open data. حسب Larissa Brazolotto Ferreira (17671168)

    منشور في 2025
    "…</p><p>Results</p><p>There was a significant decrease in BMD in the lumbar spine (1.107 ± 0.109 and 1.075 ± 0.112 g/cm<sup>2</sup>; <i><i>p</i></i> < 0.001), total body (1.135 ± 0.086 and 1.119 ± 0.085 g/cm<sup>2</sup>; <i><i>p</i></i> < 0.001), and total proximal femur over the six months of EBF compared to the values obtained from the same EBF group at 15 days postpartum (mean percentage decreases in BMD of −3.4 ± 3.7% (<i><i>p</i></i> < 0.001) in lumbar spine, −2.5 ± 3.4% (<i><i>p</i></i> < 0.001) in total proximal femur, and −1.7 ± 1.9% (<i><i>p</i></i> = 0.001) in total body). …"